Danaher Corporation $DHR Stake Lifted by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC grew its position in shares of Danaher Corporation (NYSE:DHR) by 1.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 214,555 shares of the conglomerate’s stock after acquiring an additional 3,727 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Danaher were worth $44,793,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Rovin Capital UT ADV grew its position in Danaher by 9.5% in the 3rd quarter. Rovin Capital UT ADV now owns 3,001 shares of the conglomerate’s stock worth $595,000 after purchasing an additional 261 shares during the last quarter. Florida Trust Wealth Management Co raised its stake in Danaher by 1.0% during the 3rd quarter. Florida Trust Wealth Management Co now owns 15,856 shares of the conglomerate’s stock valued at $3,143,000 after acquiring an additional 153 shares in the last quarter. Tred Avon Family Wealth LLC bought a new position in shares of Danaher in the third quarter worth $1,080,000. FAS Wealth Partners Inc. increased its holdings in shares of Danaher by 4.7% during the third quarter. FAS Wealth Partners Inc. now owns 11,066 shares of the conglomerate’s stock valued at $2,194,000 after purchasing an additional 495 shares during the period. Finally, Sierra Legacy Group raised its stake in shares of Danaher by 9.1% during the third quarter. Sierra Legacy Group now owns 6,005 shares of the conglomerate’s stock valued at $1,191,000 after purchasing an additional 500 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 30,248 shares of company stock valued at $6,609,663. Insiders own 11.20% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DHR. Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. The Goldman Sachs Group initiated coverage on Danaher in a research note on Tuesday, December 9th. They issued a “buy” rating and a $265.00 target price on the stock. Wells Fargo & Company increased their price target on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Robert W. Baird set a $247.00 price objective on Danaher in a research report on Wednesday, October 22nd. Finally, Guggenheim raised their price target on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 2nd. Twenty-one analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $251.87.

Danaher Stock Performance

NYSE DHR opened at $234.32 on Wednesday. The firm has a market cap of $165.51 billion, a price-to-earnings ratio of 48.31, a PEG ratio of 4.20 and a beta of 0.89. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The company has a 50 day moving average of $229.17 and a 200-day moving average of $212.44.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s revenue was up 4.4% on a year-over-year basis. During the same period last year, the firm posted $1.71 EPS. On average, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. Danaher’s dividend payout ratio is currently 26.39%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.